VA vs DA for Newly Diagnosed Hig-risk AML

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
VA vs DA for Newly Diagnosed Hig-risk AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2 / Phase 3	2026-09-02		NCT05939180

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The First Affiliated Hospital of Soochow University	164

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ethical Committee of the First Affliated Hospital of Soochow University	Suzhou	China	2
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology	Suzhou	China	6

Clinical trials